Bicycle Therapeutics plc (BCYC)
NASDAQ: BCYC · Real-Time Price · USD
6.50
-0.10 (-1.52%)
At close: Nov 14, 2025, 4:00 PM EST
6.48
-0.02 (-0.31%)
After-hours: Nov 14, 2025, 4:10 PM EST

Bicycle Therapeutics Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 20202016 - 2019
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2016 - 2019
28.3435.2826.9814.4611.710.39
Upgrade
Revenue Growth (YoY)
-23.20%30.76%86.52%23.65%12.58%-24.72%
Upgrade
Cost of Revenue
239.24172.97156.581.6144.8833.15
Upgrade
Gross Profit
-210.9-137.69-129.52-67.15-33.18-22.76
Upgrade
Selling, General & Admin
79.1272.1860.4349.5132.4429.2
Upgrade
Operating Expenses
79.1272.1860.4349.5132.4429.2
Upgrade
Operating Income
-290.02-209.87-189.95-116.65-65.62-51.96
Upgrade
Interest Expense
-0.2-1.73-3.26-3.34-2.98-0.46
Upgrade
Interest & Investment Income
32.8934.28145.760.120.68
Upgrade
EBT Excluding Unusual Items
-257.33-177.32-179.21-114.24-68.48-51.73
Upgrade
Other Unusual Items
4.483.52----
Upgrade
Pretax Income
-252.86-173.8-179.21-114.24-68.48-51.73
Upgrade
Income Tax Expense
-2.2-4.771.46-1.52-1.66-0.72
Upgrade
Net Income
-250.66-169.03-180.66-112.72-66.82-51.01
Upgrade
Net Income to Common
-250.66-169.03-180.66-112.72-66.82-51.01
Upgrade
Shares Outstanding (Basic)
695836302519
Upgrade
Shares Outstanding (Diluted)
695836302519
Upgrade
Shares Change (YoY)
34.28%63.54%20.00%18.35%30.90%73.34%
Upgrade
EPS (Basic)
-3.62-2.90-5.08-3.80-2.67-2.66
Upgrade
EPS (Diluted)
-3.62-2.90-5.08-3.80-2.67-2.66
Upgrade
Free Cash Flow
-241.87-165.96-63.56-105.1-16.82-18.99
Upgrade
Free Cash Flow Per Share
-3.49-2.85-1.79-3.54-0.67-0.99
Upgrade
Gross Margin
-----283.69%-219.05%
Upgrade
Operating Margin
-1023.39%-594.96%-704.13%-806.56%-560.98%-500.10%
Upgrade
Profit Margin
-884.51%-479.18%-669.72%-779.35%-571.25%-490.95%
Upgrade
Free Cash Flow Margin
-853.49%-470.47%-235.61%-726.67%-143.83%-182.76%
Upgrade
EBITDA
-283.23-202.7-183.4-112.96-64.21-50.68
Upgrade
D&A For EBITDA
6.797.176.553.691.411.28
Upgrade
EBIT
-290.02-209.87-189.95-116.65-65.62-51.96
Upgrade
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q